Why Does The Us Have A Stockpile Of Monkeypox Vaccines
The US has a stockpile of Jynneos and ACAM2000 on hand not because the country was worried about an outbreak of monkeypox , but in case smallpox becomes a public threat again. Smallpox was declared eliminated in the 1980s, and the last natural outbreak in the US happened in 1949. But smallpox is usually much more severe than monkeypox, and officials worry it could be used as biological warfare.
“The stockpile was created in the event of a biological weapons attack on the United States with smallpox,” Adalja says. In this event, health officials would not be rationing vaccines or using only the newer-generation vaccine, according to Adalja.
“If there was a smallpox attack, we would be using whatever vaccines we have to be able to deal with it,” he added.
The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified health provider regarding any questions you may have about a medical condition or health objectives.
Get the CNET Now newsletter
Covid Vaccine: How Many People Are Vaccinated In The Uk
BBC News
The UK’s Covid vaccine campaign has shifted its focus to boosters – an attempt to reduce the impact of the Omicron variant.
Almost seven in 10 of those aged 12 or over in the UK have had a booster, while nine in 10 have had a single jab and more than eight in 10 have had a second dose.
But despite more than 38 million boosters, or third doses, being given so far, more people are being urged to come forward and jabs are being rolled out to all five to 11-year-olds.
What You Need To Know About Rare Breakthrough Covid
“We are continuing to investigate the number of fully vaccinated people who may have been hospitalized or passed away,” said Abigail Barker, spokesperson for the New York State Department of Health.
Even among states that track cases closely, officials cautioned data is likely incomplete. Vaccinated people who are infected but asymptomatic are probably largely missing from statistics.
Robert Long, spokesperson for Maine Department of Health and Human Services, said, “Those who have been fully vaccinated and have a breakthrough case but are not symptomatic and not part of a regular testing protocol may never be captured in these numbers.”
The CDC is now changing tactics amid new information showing that fully vaccinated people who get Covid can transmit the virus to others.
Critics of the agency like former FDA Commissioner Scott Gottlieb, said federal officials are failing to capture the overall scope of infection of Covid cases. Gottlieb told CNBC Friday, “I suspect probably one in 10 infections is actually getting reported.”
Don’t Miss: How Long Is Meningitis Vaccine Effective
World Vaccination Rates For Covid
Israel has been a global leader in vaccinating its population against COVID-19, and more than half of the Israeli population has been at least partially vaccinated.
The country’s well-trained health care providers and a digitized community-based health system that can identify high-risk persons have been major factors in the success, according to Israeli health experts. The country also has a tradition of periodic emergency preparedness exercises.
The United Arab Emirates has also been leading the world in vaccination rates. It has about the same population as Israel and contributes its rapid vaccination pace to coordinated government action, strong leadership, public awareness campaigns, and simple vaccination registration procedures using a Health Ministry app.
Why Is There A Monkeypox Vaccine Supply Problem
The US has a supply of vaccines that work against monkeypox not because it anticipated a monkeypox outbreak, but in case of another smallpox outbreak, which typically causes much more severe disease. However, the supply of Jynneos, the newer vaccine specifically approved to prevent monkeypox, has been in particularly short supply.
Officials who spoke to The New York Times said the supply issue is partly because the government waited too long to ask Bavarian Nordic, which makes Jynneos, to bottle and fill the vaccine order the US had already purchased.
Another report by the Times alleges that the US national stockpile of monkeypox and smallpox vaccines dwindled because the government never replaced the expired doses and instead put money into technology that would extend their shelf life. Part of the reason for this was that the government created the stockpile not for monkeypox but for smallpox, which is a more contagious and often more serious disease officials fear could be used in biological warfare against the US.
The US Department of Health and Human Services didn’t respond to a request for comment on the reports.
Recommended Reading: When Did The Hpv Vaccine Come Out
Percent Of Population Covered By Vaccine Purchases
If other countries aren’t vaccinated, it’s not good for the world’s health, Ezekiel Emanuel, a health policy expert and professor at the University of Pennsylvania who advised President Joe Bidens transition, told USA TODAY in late March. And its not good for returning to normal because if you want to return to normal, part of that is trade, travel, educational and other exchanges. All of that requires vaccination around the world.
Vaccination Rollout Across The United States
The United States is racing to vaccinate a population of 328 million. But local health officials are progressing at vastly different rates. Hover your cursor over each jurisdiction to explore how many doses have been administered, how many people have received vaccines, and what percentage of the population has been fully vaccinated. Click on states to view their full profiles.
Recommended Reading: Does Medica Cover Shingles Vaccine
The Risk Of Vaccine Inequity
One danger that unequal vaccination rates around the world may pose is the emergence of new variants. The longer the period of sustained community spread, the more likely the virus will mutate. The mutated variants from the unvaccinated population might be able to infect those in the vaccinated population.
Data available for some approved vaccines suggests that they still offer robust protection from severe illness and death from the most widespread existing COVID-19 variants. However, its important to limit the spread of the virus in order to prevent mutations that may reduce the efficacy of existing vaccines. As more people get vaccinated, the virus circulation is expected to decrease, which will then result in fewer mutations.
According to Kuppalli, the infectious diseases expert, vaccinated people could go to another part of the world, get exposed to a new strain of the virus not covered by the vaccine, become infected, and transmit it to other people.
It’s making sure that we protect everybody. It’s not just about life or death but it’s also thinking about the quality of life that people have after they’ve been infected with COVID, she added.
As Breakthrough Cases Increase Is A Booster Shot Needed
In Virginia, total breakthrough cases resulting in death from Covid-19 went from 17 in mid-July to 42 on Friday.
In Oklahoma, where cases are up by 67 percent, state officials broke down the data to show that for residents who got Johnson & Johnson vaccine the incidents of breakthrough were greater at 160 per 100,000 people compared to 93 per 100,000 for Moderna.
Don’t Miss: What Happens To The Spike Protein After Vaccination
What Are The Monkeypox Vaccines Who Has Immunity From The Smallpox Vaccine
The US has two vaccines in its national stockpile that work against monkeypox. Jynneos is currently being given out to people before an exposure, as well as after an exposure, as it’s a newer vaccine that’s safe for most people.
Jynneos is a new-generation vaccine approved by the US Food and Drug Administration in 2019 for monkeypox and smallpox. It’s a two-dose vaccine, with each shot given four weeks apart. It uses a weakened virus and is approved for adults 18 and older who are at high risk of getting monkeypox or smallpox.
Jynneos is the vaccine that is being shipped out and currently being used in the US monkeypox response. Because of limited supply, it’s likely you’ll only be able to book an appointment for the first dose for the time being. In New York City, for example, health officials say you’ll be contacted if you received a first dose about the second dose in the coming weeks.
ACAM2000 is a second-generation smallpox vaccine that also works against monkeypox. According to the CDC, ACAM2000 is a derivative of Dryvax, which helped eradicate smallpox. If necessary, the US Department of Health and Human Services said it’s also prepared to ship out the ACAM2000 vaccine, which is in greater supply than Jynneos but remains a second choice in the monkeypox response because it has a side effect profile that isn’t safe for certain people.
Read more: Monkeypox: What Gay and Bisexual Men Need to Know
Monkeypox Vaccine: Health Officials Trying New Method To Increase Supply
Jessica Rendall
Jessica is a Wellness News Writer who wants to help people stay informed about their health. She’s from the Midwest, studied investigative reporting at the Missouri School of Journalism and is now based in NYC.
What’s happening
The monkeypox vaccine is available to people at higher risk of getting the disease. Because supply has been so limited, health officials authorized a different vaccination method, which requires a lower dose of vaccine.
Why it matters
Vaccination is an important tool to slow the monkeypox outbreak happening in the US and other countries. Access to vaccines is crucial for people most at risk.
What it means for you
Some men who have sex with men are eligible for the vaccine, as are other people who may’ve been exposed to monkeypox.
The US Food and Drug Administration on Tuesday greenlighted a different monkeypox vaccination method, which requires a much smaller dose, potentially increasing the US supply of Jynneos up to five times.
Jynneos is the monkeypox vaccine currently available to people at higher risk of the disease. With the FDA’s decision, it can now be given as an intradermal vaccination as opposed to only a subcutaneous injection. With intradermal, the injection goes under a top layer of skin. With subcutaneous, the shot is administered deeper, under a layer of fatty tissue.
“We’re sort of playing catch-up,” said Dr. Amesh Adalja, an infectious-disease expert and senior scholar at the Johns Hopkins Center for Health Security.
Don’t Miss: What Vaccines Are Given To Children
Household Pulse Survey Shows Many Dont Trust Covid Vaccine Worry About Side Effects
The Centers for Disease Control and Prevention reports that as of December 14, roughly 85% of adults ages 18 and over in the United States had received at least one dose of a COVID-19 vaccine but 15% remained unvaccinated.
Who are the unvaccinated and why are they choosing not to get a COVID vaccine?
About 42% reported that they dont trust the COVID-19 vaccine.
According to the U.S. Census Bureaus newest phase of the experimental Household Pulse Survey , those who were unvaccinated against COVID in early December 2021, reported a variety of reasons why.
“Vaccinated” here refers to adults who have received at least one dose of any COVID vaccine, and “unvaccinated” refers to adults who have not received any.
Unvaccinated adults who responded to the survey could select more than one reason:
- About half reported that they were concerned about possible side effects of the vaccine.
- About 42% reported that they dont trust the COVID-19 vaccine.
- Less than 10% reported that they hadnt gotten the vaccine because their doctor had not recommended it.
- About 2% reported not getting the vaccine because of difficulty obtaining it.
Who Is Eligible For A Vaccine
Everyone 6 months and older is now eligible for a coronavirus vaccine, after the Food and Drug Administration authorized the use of the Pfizer and Moderna vaccines for those under 5 in June.
Four coronavirus vaccines are in use across the country, including the two-dose mRNA vaccines developed by Pfizer and Moderna, the two-dose protein-based vaccine from Novavax and the Johnson & Johnson one-dose vaccine. Although Johnson & Johnson is still available for use, regulators have suggested that people should opt for one of the mRNA vaccines because of concerns about a rare but serious blood clotting condition among those who received the companys shot.
The vaccine rollout began in December 2020, with a focus on some of the most vulnerable populations, including health care workers, residents of long-term care facilities and people 65 and older. Although eligibility for these groups initially varied by state and county, every state had made all adults eligible for the shots by April 2021, according to a Times survey.
In May 2021, the F.D.A. extended its emergency use authorization for the Pfizer vaccine to children 12 and older.
Also Check: How Long Is The Hbv Vaccination Good For
Chart: How Many Shots From Each Vaccine Manufacturer Have Been Administered
The Pfizer-BioNTech and Moderna vaccines require two doses, and the Johnson & Johnson vaccine requires only one for the recipient to be fully vaccinated. For the Pfizer-BioNTech and Moderna vaccines, a second shot should be administered about three or four weeks after the first, depending on which of the vaccines was given.
Everyone who received the Johnson & Johnson vaccine is eligible for a booster shot if it has been at least two months since their initial vaccine.
Anyone 12 or older who received the Pfizer-BioNTech or Moderna vaccine is eligible for a booster shot five months after they received their second dose.
Immunocompromised people who received the Pfizer or Moderna vaccines are eligible for a third shot four weeks after their second dose. This shot is not considered a booster, but rather part of the normal vaccination course for this group, which includes people who are receiving cancer treatment and people who have received an organ transplant, among others.
If you’re not sure whether or not you should get a booster dose of vaccine, talk to your doctor.
States Ranked By Percentage Of Population Fully Vaccinated
The CDC’s data tracker compiles data from healthcare facilities and public health authorities. It updates daily to report the total number of people in each state who have been fully vaccinated against COVID-19. The numbers reported by the CDC may vary from the numbers published on individual states’ public health websites, as there may be reporting lags between the states and the CDC.
As of 6 a.m. EDT Feb 2, a total of 211,954,555 Americans had been fully vaccinated, or 63.8 percent of the country’s population, according to the CDC’s data.
Vermont has the highest percentage of its population fully vaccinated against COVID-19, according to the CDC’s COVID-19 vaccine distribution and administration data tracker.
Below are the states and Washington, D.C., ranked by the percentage of their population that has been fully vaccinated against COVID-19, according to the CDC.
1. VermontNumber of people fully vaccinated: 495,648Percentage of population fully vaccinated: 79.43
2. Rhode IslandNumber of people fully vaccinated: 837,505Percentage of population fully vaccinated: 79.06
3. MaineNumber of people fully vaccinated: 1,042,561Percentage of population fully vaccinated: 77.56
4. ConnecticutNumber of people fully vaccinated: 2,731,560Percentage of population fully vaccinated: 76.62
5. MassachusettsNumber of people fully vaccinated: 5,270,527Percentage of population fully vaccinated: 76.47
51. Alabama
You May Like: What Is The Chickenpox Vaccine Called
The Gap Between Countries
High-income countries represent only 16% of the worlds population, yet some of them have bought enough vaccines to cover their population more than twice.
According to a ONE’s Policy team study, as of March the worlds richest countries had collectively bought 1 billion more doses than their citizens need. The rest of the world had only been able to secure 2.5 billion doses not enough to vaccinate their populations.
Summary Of Data Publicly Reported By The Centers For Disease Control And Preventiondate: 8/03/22
The American Academy of Pediatrics recommends COVID-19 vaccination for all children and adolescents 6 months of age and older who do not have contraindications using a vaccine authorized for use for their age. See AAP policy.
In this report, drawing on data posted by the Centers for Disease Control and Prevention as of 8.03.22, the AAP reports progress in vaccinating US children, including the 50 States and District of Columbia.
The report covers the vaccine data available for children under 5, and the longer-term data for children 5-11 years and for children 12-17 years of age.
See link below to download the full AAP report. Note: Individual state web sites may have additional or more recent information.
Children Under 5 Years:
As of August 3, 2022, the CDC recorded:
900,000 US children ages 6 months-4 years have received at least one dose of COVID-19 vaccine
- Representing 5% of 6 months-4 year-olds
- This past week about 93,000 received their first vaccine dose.
About 16.5 million children 6 months-4 year-olds had yet to receive their first COVID-19 vaccine dose.
Children Ages 5-11 Years:
10.4 million US children ages 5-11 have received at least one dose of COVID-19 vaccine
- Representing 37% of 5-11 year-olds
8.4 million US children ages 5-11 completed the 2-dose vaccination series
- Representing 30% of 5-11 year-olds
About 17.9 million children 5-11 had yet to receive their first COVID-19 vaccine dose. This past week about 51,000 received their first vaccine dose.
Read Also: Is Hpv Vaccine Mandatory In Texas
What’s The Nation’s Progress On Vaccinations
At least261,591,428people or79%of the population have received at least one dose.
Overall,223,035,566people or67%of the population are considered fully vaccinated.
Additionally,107,490,375people or32%of the population have received a booster dose.
Percent of people receiving vaccines in the US
In the US,794,231,535 doses have been distributed so far, with76%or 604,235,972of the doses used.
How Many Doses Have Been Donated By Each Country
These charts show the cumulative number of doses donated to the COVAX initiative by different countries, broken down by whether the donations have only been announced, actually donated, or delivered to the recipients. This is only available for a select number of countries for which the COVID-19 Task Force reports the necessary data.
The first chart shows the number of doses donated, while the next three charts show that number adjusted for:
COVID-19 Vaccines Global Access
COVAX is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations , and the World Health Organization . COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines.
Also Check: Does Cvs Have The Shingles Vaccine